Metastasis-directed therapy: a new standard for oligorecurrent prostate cancer?
Oncotarget
.
2018 Sep 28;9(76):34196-34197.
doi: 10.18632/oncotarget.26152.
Authors
Thomas Zilli
1
,
Piet Ost
1
Affiliation
1
Department of Radiation Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
PMID:
30344935
PMCID:
PMC6188143
DOI:
10.18632/oncotarget.26152
No abstract available
Keywords:
SBRT; oligometastasis; prostate cancer; radiotherapy.
Publication types
Editorial